Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Listen to the latest hemonc news from international experts

Revolutionary immunotherapies for lymphoma

Immunotherapy has emerged in recent years as an effective novel treatment for lymphoma, with studies constantly striving to identify new molecules that could help patients.  Here, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, of Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the current state of lymphoma immunotherapy research, including follow-up data on the efficacy of rituximab, and information on several newer treatments, such as ADCC-activating monoclonal antibodies and antibody-drug conjugates. Dr Collins also discusses some of the most exciting data yet to be released in the field, such as that from the ECHELON-1 trial and the use of CAR T-cells in lymphoma. This feature was recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.

Date: 2nd February 2018

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter